Novotalk

Novotalk Overview

Novotalk develops on-demand (asynchronous), self-directed speech and language teletherapy solutions that allow individuals with speech impairments to learn, practice, gain, and maintain intelligible speech remotely, independently, and discreetly. The companys first commercialized product is a patented web and mobile application that provides self-directed speech therapy and training to people who stutter, enabling regular Novotalk users to experience fluent speech. The first version is in Hebrew and English. Novotalk has signed a joint venture agreement with Mount Sinai Health System in New York for commercialization in North America and future research and development collaborations. Novotalk is available to patients in Israel in collaboration with Hadassah Medical Center in Jerusalem.

Cumulative Funding Raised Over Time ($)

Latest News

Jan 22, 2019 · www.jpost.com

growth-positive

https://www.jpost.com/Israel-News/Mount-Sinai-announces-partnership-with-Israeli-start-up-563710

Novotalk, an Israeli start-up that provides therapeutic language and speech technologies, has signed a joint venture contract with New Yorks Mount Sinai Health System. The company offers on-demand, self-directed speech and language courses for individuals with speech problems. Novotalks algorithms provide more accurate feedback than clinicians, making it unnecessary for clinicians to be present during therapy sessions. The company plans to expand its services to North America, starting with the New York metropolitan area by the end of 2018. Novotalks products will then be expanded to other states. The partnership with Mount Sinai gives the start-up credibility and access to a larger market.

Partners

Jul 25, 2018 · www.mountsinai.org

growth-positive

Mount Sinai and Novotalk sign a joint venture agreement to bring innovative speech and language therapeutic technologies to patients

Mount Sinai Health System has entered into an exclusive joint venture agreement with Novotalk to commercialize speech and language solutions for patients with speech impairments in the US and Canada. The first product to be launched is an on-demand tele-therapy solution for chronic stuttering. Mount Sinais clinical teams will provide oversight and quality guidelines for the services. As part of the partnership, Mount Sinai Ventures has made a financial investment in Novotalk. The Novotalk products are expected to launch in the New York metropolitan area in the fourth quarter of 2018 and will be rolled out to other states shortly after.

PartnersInvestment

May 23, 2017 · masschallenge.org

MassChallenge Israel Announces 2017 Class

Nov 4, 2015 · www.haaretz.com

growth-positive

The Israeli apps that will help give stutterers a voice

The article discusses the development of a mobile app called NiNispeech, designed to help treat stuttering. The app is based on algorithms that identify and measure stuttering in real time, providing a measurable objective scale of the severity of the problem and improvement. It also includes an environment for long-term practice, combining a video chat room and a social network with games and activities. The app aims to address the difficulties in turning progress achieved in therapy into a permanent situation. The article highlights the challenges faced by stutterers and the need for accessible and effective treatment methods. The Israel Stuttering Association is holding a week on awareness of stuttering, focusing on treatment methods.

Customers

Funding

Team Members

1

Employees: 1-10

Web & Social Links

Locations

Rabbi Akiva Street 86, Bnei Brak, Israel

845 Third Avenue, New York, NY, USA

Photos & Videos

3 item(s)

Novotalk Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info